TriplePoint Venture Growth BDC (NYSE:TPVG – Get Rating) had its price target reduced by equities research analysts at LADENBURG THALM/SH SH from $14.50 to $13.50 in a research note issued on Thursday, The Fly reports. LADENBURG THALM/SH SH’s price objective would indicate a potential upside of 37.20% from the stock’s current price. A number of […]
Tempest Therapeutics (NASDAQ:TPST – Get Rating) had its price objective increased by LADENBURG THALM/SH SH from $8.00 to $14.00 in a report released on Friday, The Fly reports. A number of other research analysts have also recently issued reports on TPST. Piper Sandler lowered their price objective on Tempest Therapeutics from $10.00 to $6.00 and […]
Avadel Pharmaceuticals (NASDAQ:AVDL – Get Rating) had its target price lifted by analysts at LADENBURG THALM/SH SH from $14.50 to $16.00 in a research report issued to clients and investors on Tuesday, The Fly reports. LADENBURG THALM/SH SH’s price target indicates a potential upside of 36.40% from the company’s current price. Other research analysts have […]
VICI Properties (NYSE:VICI – Get Rating) had its price objective raised by stock analysts at LADENBURG THALM/SH SH from $34.50 to $37.00 in a note issued to investors on Monday, The Fly reports. LADENBURG THALM/SH SH’s target price would indicate a potential upside of 9.56% from the stock’s current price. A number of other analysts […]
LADENBURG THALM/SH SH initiated coverage on shares of Acrivon Therapeutics (NASDAQ:ACRV – Get Rating) in a report released on Thursday morning, The Fly reports. The firm issued a buy rating and a $22.00 target price on the stock. Separately, HC Wainwright assumed coverage on shares of Acrivon Therapeutics in a report on Thursday, April 20th. […]